Convergence: FDA officials tout open door policy for ACNU nonprescription pathway
Regulatory NewsEmily Hayes
OTCOver the counter drugs (OTCs)PharmaceuticalsUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsEmily HayesOTCOver the counter drugs (OTCs)PharmaceuticalsUnited StatesUS Food and Drug Administration (FDA)